TIGAR Protects Cochlear Hair Cells against Teicoplanin-Induced Damage

Qiongmin Zhang1,2, Zhiqun Yao1,2, Fang Chen1,2

  • 1Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong, China.

Molecular Neurobiology
|March 21, 2023
PubMed

Insights

Teicoplanin causes cochlear hair cell death by reducing TIGAR expression. Upregulating TP53-induced glycolysis and apoptosis regulator (TIGAR) protects against this damage, suggesting TIGAR as a target for preventing teicoplanin ototoxicity.

Area of Science:

  • Ototoxicity research
  • Cellular and molecular biology
  • Pharmacology

Background:

  • Teicoplanin, an antibiotic for severe staphylococcal infections, is suspected of ototoxicity.
  • The role of TP53-induced glycolysis and apoptosis regulator (TIGAR) in protecting cochlear hair cells from damage is unknown.
  • TIGAR is known to protect neurons from cisplatin damage.

Purpose of the Study:

  • To investigate the effects of teicoplanin on cochlear hair cells (HCs).
  • To determine the role of TIGAR in teicoplanin-induced ototoxicity.
  • To explore TIGAR as a potential therapeutic target for preventing hearing loss.

Main Methods:

  • In vitro study using HEI-OC1 cells and primary cochlear HCs.
  • Teicoplanin treatment to induce cell death and assess TIGAR expression.
  • TIGAR expression manipulated using recombinant adenovirus (upregulation) and shRNA (downregulation).
  • Assessment of cell viability, apoptosis, and reactive oxygen species (ROS) levels.
  • Antioxidant therapy with N-acetyl-L-cysteine.

Main Results:

  • Teicoplanin induced dose-dependent cell death in HCs and HEI-OC1 cells.
  • Teicoplanin treatment significantly decreased TIGAR expression.
  • TIGAR overexpression enhanced cell viability, reduced apoptosis, and lowered ROS levels.
  • TIGAR downregulation decreased cell viability, increased apoptosis, and elevated ROS levels.
  • N-acetyl-L-cysteine treatment reduced ROS, prevented cell death, and restored p38 signaling.

Conclusions:

  • Teicoplanin-induced ototoxicity involves a decrease in TIGAR expression.
  • TIGAR plays a protective role against teicoplanin-induced damage to cochlear HCs.
  • TIGAR represents a potential novel therapeutic target for mitigating teicoplanin-induced hearing loss.